Stephen Rocamboli

Stephen Rocamboli

Director/Board Member at ESPERION THERAPEUTICS, INC.

Net worth: 44 237 $ as of 30/03/2024

52 year
Health Technology
Finance
Commercial Services

Profile

Stephen Charles Rocamboli was the founder of Pear Tree Pharmaceuticals, Inc. (founded in 2008) where he held the title of President & Secretary from 2008 to 2018.
He is currently working as an Independent Director at Esperion Therapeutics, Inc., a Director at Cortice Biosciences, Inc., an Independent Director at TFF Pharmaceuticals, Inc. (since 2018), and a Director at Androvia Life Sciences.
In his former positions, he served as Chairman & Chief Executive Officer at Perla Therapeutics, Inc., Non-Executive Chairman & Secretary at VioQuest Pharmaceuticals, Inc. (from 2003 to 2009), Senior Managing Director & General Counsel at Paramount BioCapital, Inc. (from 1999 to 2007), and held various director roles at Cutanea Life Sciences, Inc., Foresight Biotherapeutics, Inc., Chitina Sciences, Inc., and Cordova Sciences, Inc. He also worked as Special Counsel at Wyrick Robbins Yates & Ponton LLP (from 2014 to 2015), Partner at Orion Biomedical Fund LP (from 1999 to 2007), and Deputy General Counsel at Paramount BioSciences LLC (from 1999 to 2004).
Additionally, he served as Secretary & Chief Business Officer at Candel Therapeutics, Inc. (from 2015 to 2020) and as General Partner at Integrin Partners LLC (from 2010 to 2015).
He was also a Partner at Beijing International Group LLC (from 2010 to 2012).
Mr. Rocamboli obtained an undergraduate degree from State University of New York at Albany and a graduate degree from Fordham University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/06/2023 13,261 ( 0.01% ) 35 539 $ 30/03/2024
17/04/2024 1,440 ( 0.06% ) 8 698 $ 30/03/2024

Stephen Rocamboli active positions

CompaniesPositionStart
TFF PHARMACEUTICALS, INC. Director/Board Member 30/11/2018
ESPERION THERAPEUTICS, INC. Director/Board Member 27/04/2022
Androvia Life Sciences Director/Board Member -
Director/Board Member -
All active positions of Stephen Rocamboli

Former positions of Stephen Rocamboli

CompaniesPositionEnd
CANDEL THERAPEUTICS, INC. General Counsel 30/04/2020
Founder 30/04/2018
Corporate Officer/Principal 31/03/2015
Director/Board Member 31/12/2014
General Counsel 31/12/2014
See the detail of Stephen Rocamboli's experience

Training of Stephen Rocamboli

State University of New York at Albany Undergraduate Degree
Fordham University School of Law Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephen Rocamboli's experience

Connections

75

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
VIOQUEST PHARMACEUTICALS, INC.

Health Technology

ESPERION THERAPEUTICS, INC.

Health Technology

CANDEL THERAPEUTICS, INC.

Health Technology

TFF PHARMACEUTICALS, INC.

Health Technology

Private companies14

Finance

Finance

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Orion Biomedical Fund LP

Finance

Health Technology

Commercial Services

Beijing International Group LLC

Androvia Life Sciences

Perla Therapeutics, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Stephen Rocamboli